Health Tip: Treating Dry Eye
-- Dry eye syndrome occurs when your eyes do not make enough tears. As adults get older, they are more likely to have medical conditions that trigger dry eye, such as autoimmune diseases, diabetes, stroke and thyroid problems, the AARP says. Certain... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 14, 2019 Category: General Medicine Source Type: news

Checkpoint Inhibitors'Not Off Table' in Autoimmune Disease Checkpoint Inhibitors'Not Off Table' in Autoimmune Disease
Patients with NSCLC and a history of autoimmune disease may, in some situations, be candidates for immune checkpoint inhibitors, says Dr Mark Kris.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 13, 2019 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

When good cells go bad: Regulating the ms-causing properties of Th17 cells
(Osaka University) Multiple sclerosis (MS) and other inflammatory autoimmune diseases are characterized by localized inflammation in various tissues, including the brain. Using a mouse model of MS, a team led by researchers from Osaka University identified a major regulator of Th17 cell-associated pathogenic inflammatory processes. The protein, Satb1, enhances the expression of genes promoting inflammation and suppresses genes needed to prevent autoimmunity. By targeting this protein, novel therapies may be able to attenuate inflammatory autoimmune diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 13, 2019 Category: International Medicine & Public Health Source Type: news

IFM Therapeutics launches new spinout aimed at Parkinson's, lupus and other diseases
Boston biotech IFM Therapeutic LLC is taking a second major step out from drug giant Bristol-Myers Squibb's wake this week, spinning out its second subsidiary focused on developing treatments for autoimmune and central nervous system diseases. IFM Due (pronounced du-way) was launched Feb. 11 by the team behind IFM Therapeutics, which Bristol-Myers Squibb (NYSE: BMY) purchased in 2017 for $300 million upfront and upwards of $2 billion in milestone payments. Expanding on its founders' efforts at… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 11, 2019 Category: American Health Authors: Allison DeAngelis Source Type: news

Masterswitch discovered in body's immune system
(University of Manchester) Scientists have discovered a critical part of the body's immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans. Professor Graham Lord, from The University of Manchester, led the study, which could translate into treatments for autoimmune diseases including Cancer, Diabetes, Multiple Sclerosis and Crohn's Disease within a few years. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 11, 2019 Category: Cancer & Oncology Source Type: news

Price of life-changing drug for college senior's rare disease hiked from free to $375,000
Will Schuller would be confined to a wheelchair - if not worse - without medication for his rare autoimmune disease, LEMS. The drug was free, but a drug company hiked the price to $375K. (Source: the Mail online | Health)
Source: the Mail online | Health - February 8, 2019 Category: Consumer Health News Source Type: news

Pathios Therapeutics and Sygnature Discovery sign a strategic and innovative partnership & nbsp; to develop first in class therapies in autoimmune disease and immuno-oncology
Pathios Therapeutics ("Pathios"), an innovative biotech company focused on the development of first in class therapies for autoimmune diseases and immuno-oncology and Sygnature Discovery... (Source: The Scientist)
Source: The Scientist - February 7, 2019 Category: Science Tags: The Marketplace The Scientist Source Type: news

Mosaic-like gene deletion and duplication pattern shaping the immune system discovered
(Bar-Ilan University) A team of researchers from Bar-Ilan University has developed a computational tool for analyzing genetic changes related to the immune system. With this new development, the onset of many autoimmune diseases, such as multiple sclerosis and celiac disease, infectious diseases, such as hepatitis C and flu, and various forms of cancer may be predicted. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 7, 2019 Category: Biology Source Type: news

How lung tissue forms immune cell hubs in times of need
(Babraham Institute) Research uncovers how lung tissue is remodelled to support an immune response to influenza. The findings hold promise for broader immunisation against flu and the development of new therapeutic strategies for autoimmune diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 5, 2019 Category: Infectious Diseases Source Type: news

OU researcher developing new approach for early intervention of lupus
(University of Oklahoma) A University of Oklahoma researcher, Si Wu, and collaborators from the Oklahoma Medical Research Foundation and Indiana University, are developing new strategies leading to diagnosis and early intervention of lupus, an autoimmune disease that may affect up to 1.5 million Americans. The National Institutes of Health is funding the OU research with a $2 million grant over a five-year period. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 1, 2019 Category: International Medicine & Public Health Source Type: news

A novel, preventive approach to treating rheumatoid arthritis
Novel therapies being developed by EU- and industry-funded researchers could prevent and cure rheumatoid arthritis by tackling the autoimmune disease in the very early stages, before debilitating symptoms occur. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - February 1, 2019 Category: Research Source Type: news

Apellis names exec to lead Europe operations
Apellis Pharmaceuticals Inc. is expanding into Europe and has hired an executive to oversee those operations. Thomas Lackner joined Crestwood, Ky.-based Apellis as senior vice president, head of Europe. In his new role, Thomas will build out the launch organization in Europe for APL-2, Apellis' signature treatment. APL-2 is a synthetic peptide that can help treat autoimmune and inflammatory diseases, so me of which have no meaningful treatment. Apellis (Nasdaq:APLS) is conducting late-stage clinical… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 31, 2019 Category: Health Management Authors: Carolyn Tribble Greer Source Type: news

Apellis names exec to lead Europe operations
Apellis Pharmaceuticals Inc. is expanding into Europe and has hired an executive to oversee those operations. Thomas Lackner joined Crestwood, Ky.-based Apellis as senior vice president, head of Europe. In his new role, Thomas will build out the launch organization in Europe for APL-2, Apellis' signature treatment. APL-2 is a synthetic peptide that can help treat autoimmune and inflammatory diseases, so me of which have no meaningful treatment. Apellis (Nasdaq:APLS) is conducting late-stage clinical… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 31, 2019 Category: Biotechnology Authors: Carolyn Tribble Greer Source Type: news

America's dark vaccine history - A look at the pertussis vaccine
(Natural News) Vaccination is often heralded as the greatest scientific achievement in modern medical history, but science and case history shows that vaccination is not synonymous with immunization. Vaccination often fails to prevent targeted diseases and can actually spread disease (shedding). Vaccination also perpetuates viral and bacterial mutations and causes complications, including lifelong autoimmune issues... (Source: NaturalNews.com)
Source: NaturalNews.com - January 31, 2019 Category: Consumer Health News Source Type: news

America's dark vaccine history A look at the pertussis vaccine
(Natural News) Vaccination is often heralded as the greatest scientific achievement in modern medical history, but science and case history shows that vaccination is not synonymous with immunization. Vaccination often fails to prevent targeted diseases and can actually spread disease (shedding). Vaccination also perpetuates viral and bacterial mutations and causes complications, including lifelong autoimmune issues... (Source: NaturalNews.com)
Source: NaturalNews.com - January 31, 2019 Category: Consumer Health News Source Type: news

Atopic and Autoimmune Diseases Up Risk of IBS, Functional Dyspepsia
(MedPage Today) -- Association was independent of psychological distress (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - January 30, 2019 Category: Dermatology Source Type: news

Dietary fiber for your bones: Researchers discover that increased intake soothes symptoms of autoimmune disease, leading to stronger bones
(Natural News) Eating a diet high in fiber may help fend off inflammatory diseases and significantly improve joint health and bone integrity, a study published in the journal Nature Communications revealed. The study also showed that the metabolites produced in a high-fiber diet — and not the intestinal bacteria themselves — play a central role... (Source: NaturalNews.com)
Source: NaturalNews.com - January 29, 2019 Category: Consumer Health News Source Type: news

Antiphospholipid Syndrome: Insights Into a Rare Autoimmune Disease Antiphospholipid Syndrome: Insights Into a Rare Autoimmune Disease
A conversation with Dr Doruk Erkan about the proper diagnosis and management of this life-threatening clotting disease.Hospital for Special Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 29, 2019 Category: Consumer Health News Tags: Rheumatology Expert Interview Source Type: news

The transcription factor SP3 drives TNF-{alpha} expression in response to Smac mimetics
The controlled production and downstream signaling of the inflammatory cytokine tumor necrosis factor–α (TNF-α) are important for immunity and its anticancer effects. Although chronic stimulation with TNF-α is detrimental to the health of the host in several autoimmune and inflammatory disorders, TNF-α—contrary to what its name implies—leads to cancer formation by promoting cell proliferation and survival. Smac mimetic compounds (SMCs), small-molecule antagonists of inhibitor of apoptosis proteins (IAPs), switch the TNF-α signal from promoting survival to promoting death in c...
Source: Signal Transduction Knowledge Environment - January 29, 2019 Category: Science Authors: Beug, S. T., Cheung, H. H., Sanda, T., St-Jean, M., Beauregard, C. E., Mamady, H., Baird, S. D., LaCasse, E. C., Korneluk, R. G. Tags: STKE Research Articles Source Type: news

Blisters Not Required to Diagnose Pemphigoid Blisters Not Required to Diagnose Pemphigoid
The presence of blisters is not required to make the diagnosis of pemphigoid, according to a new study of this common cutaneous autoimmune disease.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 18, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

UCLA scientists create a renewable source of cancer-fighting T cells
A study by UCLA researchers is the first to demonstrate a technique for coaxing pluripotent stem cells — which can give rise to every cell type in the body and which can be grown indefinitely in the lab — into becoming mature T cells capable of killing tumor cells.The technique uses structures called artificial thymic organoids, which work by mimicking the environment of the thymus, the organ in which T cells develop from blood stem cells.T cells are cells of the immune system that fight infections, but also have the potential to eliminate cancer cells. The ability to create them from self-renewing pluripotent ...
Source: UCLA Newsroom: Health Sciences - January 17, 2019 Category: Universities & Medical Training Source Type: news

Experimental Stem Cell Therapy Shows Promise In Multiple Sclerosis
BOSTON (CBS) — An experimental treatment for multiple sclerosis is showing promise. A new study finds a single stem cell transplant could stop or delay symptoms better than some medications. Multiple sclerosis is an autoimmune disease in which the body attacks the myelin or protective covering around nerve cells. Current drugs used to treat MS can have serious side effects, can be expensive and have varying degrees of success. In a small clinical trial of out of Northwestern University Feinberg School of Medicine, researchers found that while most patients on standard therapy had progression of their disease ove...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 16, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall Local TV Multiple Sclerosis Stem Cell Transplant Source Type: news

Molecular Mycology: Current Approaches to Fungal Pathogenesis
Fungal diseases are significant causes of mortality and morbidity in both the developed and the developing world. The recent increases in the incidence and severity of invasive fungal infections are directly attributable to new susceptible patient populations. Examples of these large, at-risk populations include patients with AIDS; hospitalized patients being treated for cancer and autoimmune disorders; andthose receiving organ transplants.Courses& Workshops (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - January 16, 2019 Category: Respiratory Medicine Authors: helenfindon Source Type: news

Six decades of research concludes that gluten grain consumption increases the risk of both neurological and psychiatric problems
(Natural News) Gluten barely registered on most people’s radars until recently, but it’s something researchers have been investigating for more than six decades. These days, we hear a lot about gluten intolerance, with some people having legitimate autoimmune disorders like Celiac disease, completely unable to consume it while others are simply following a celebrity fad... (Source: NaturalNews.com)
Source: NaturalNews.com - January 16, 2019 Category: Consumer Health News Source Type: news

ICYMI: New study reinforces dangers of proposed IPI model
Stakeholder after stakeholder has raised concerns that the Department of Health and Human Services ’ proposed International Pricing Index (IPI) Model would put patient access to medicines in Medicare Part B at risk – medicines that are necessary to treat complex conditions like cancer, rheumatoid arthritis and autoimmune diseases. One of the most common concerns is that patients in the United States will experience the same access restrictions that patients face abroad if the U.S. government proceeds with copying the flawed pricing practices of foreign governments. Recently,IHS Markit released a study that show...
Source: The Catalyst - January 15, 2019 Category: Pharmaceuticals Tags: Part B Access Medicare Source Type: news

Stem cell therapy for relapsing MS proves effective and safe, study finds
An experimental stem cell therapy proved effective and safe in patients with a relapsing form of multiple sclerosis (MS), an autoimmune disease that affects the central nervous system, new research finds. (Source: CNN.com - Health)
Source: CNN.com - Health - January 15, 2019 Category: Consumer Health News Source Type: news

EU and Canada award € 8.65 million to project to ease genomic and health data sharing
(Bar-Ilan University) The European Union (EU) and the Canadian government have awarded the international iReceptor Plus consortium € 8.65 million to promote human immunological data storage, integration and controlled sharing for a wide range of clinical and scientific purposes. The four-year project aims to develop an innovative platform to integrate distributed repositories of Adaptive Immune Receptor Repertoire sequencing (AIRR-seq) data for enabling improved personalized medicine and immunotherapy in cancer, inflammatory and autoimmune diseases, allergies and infectious diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 15, 2019 Category: Cancer & Oncology Source Type: news

Checkpoint Inhibitors: Effective in NSCLC Patients With Pre-existing Autoimmune Disease?
The results, described by an expert as “very interesting” and a “a bit surprising, " focused on the impact of autoimmune antibodies on anti –PD-1 therapy. (Source: CancerNetwork)
Source: CancerNetwork - January 15, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news

UCLA researchers correct genetic mutation that causes IPEX, a life-threatening autoimmune syndrome
UCLA researchers led by Dr. Donald Kohn have created a method for modifying blood stem cells to reverse the genetic mutation that causes a life-threatening autoimmune syndrome called IPEX. The gene therapy, which was tested in mice, is similar to the technique Kohn has used to cure patients with another immune disease, severe combined immune deficiency, or SCID, also known as bubble baby disease.The workis described in a study published in the journal Cell Stem Cell.IPEX is caused by a mutation that prevents a gene called FoxP3 from making a protein needed for blood stem cells to produce immune cells called regulatory T ce...
Source: UCLA Newsroom: Health Sciences - January 10, 2019 Category: Universities & Medical Training Source Type: news

Munchausen by proxy syndrome mimicking childhood-onset systemic lupus erythematosus - Kuhne ACA, Pitta AC, Galassi SC, Gon çalves AMF, Cardoso ACA, Paz JA, Campos LMA, Silva CA.
Childhood-onset systemic lupus erythematosus (cSLE) is a chronic inflammatory multisystem autoimmune disease that requires multiple differential diagnoses. Munchausen by proxy syndrome (MBPS) is a form of child abuse, where a caregiver intentionally create... (Source: SafetyLit)
Source: SafetyLit - January 10, 2019 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Cygnal Therapeutics Appoints Pearl S. Huang as Chief Executive Officer
CAMBRIDGE, Mass., Jan. 8, 2019 -- (Healthcare Sales & Marketing Network) -- Cygnal Therapeutics, a biotechnology company pioneering the field of exoneural biology for the treatment of cancer, autoimmune conditions, inflammation, and other diseases, today ... Biopharmaceuticals, Personnel Cygnal Therapeutics, exoneural biology, exoneural (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 8, 2019 Category: Pharmaceuticals Source Type: news

Vital Therapies pulls the trigger on Immunic share swap
Vital Therapies (NSDQ:VTL) said today that it inked a deal to swap shares with Germany-based Immunic, transitioning its efforts to focus on Immunic’s pipeline of drugs for chronic inflammatory and autoimmune diseases. Once the deal is closed, Vital Therapies plans to operate under the name Immunic and trade on the Nasdaq market. Get the full story at our sister site, Drug Delivery Business News. The post Vital Therapies pulls the trigger on Immunic share swap appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - January 7, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Featured Mergers & Acquisitions Pharmaceuticals Wall Street Beat immunic Vital Therapies Source Type: news

Pfizer initiates phase 2b/3 clinical trial for PF-06651600, an oral JAK3 inhibitor, for the treatment of patients with moderate to severe alopecia areata
Pfizer Inc. (NYSE: PFE) announced the initiation of a Phase 2b/3 clinical trial for its oral JAK3 inhibitor, PF-06651600, for the treatment of patients with moderate to severe alopecia areata, a chronic autoimmune skin disease that causes hair loss on the scalp, face, or body, and currently has no approved therapies. (Source: World Pharma News)
Source: World Pharma News - January 5, 2019 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

Researchers Think Some Food Additives May Contribute To Celiac Disease
BOSTON (CBS) – New research suggests that a common food additive may contribute to or even cause celiac disease and experts are calling for warnings on food labels until further research is done. Celiac disease is an autoimmune disorder where gluten causes the immune system to attack the gut. While genetics play a role, what actually triggers celiac disease is unclear. Now researchers believe food additives may contribute, in particular, microbial transglutaminase, which is used in the processing of sausages, cheese, bread and other products. More research is needed to determine whether this food additive is a direc...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 3, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated Local Watch Listen Celiac Disease Dr. Mallika Marshall Gluten Source Type: news

Autoimmune Sequelae Following Rituximab Therapy Autoimmune Sequelae Following Rituximab Therapy
A new review provides insight into the mechanisms involved in the development of new autoimmune disease among patients receiving rituximab treatment.Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 26, 2018 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Alopecia Areata: A Review of Disease Pathogenesis Alopecia Areata: A Review of Disease Pathogenesis
This article offers new insights into the pathophysiological mechanisms involved in the etiology of alopecia areata, an incurable autoimmune disorder.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 24, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Book Review: Neurobiology for Clinical Social Work, 2nd Ed.
While social workers have long espoused the importance of relationships and their impact on our psychological functioning, truly understanding those relationships requires understanding the brain as a social organ. As Louis Cozolino, one of the nation’s leading authorities on neuroscience, says, “Each generation of mental health practitioners needs to be taught that although we look like separate beings, we are connected in deep and profound ways we are still coming to understand.” In their latest edition of Neurobiology for Clinical Social Work: Theory and Practice, Janet R. Shapiro and Jeffrey S. Appleg...
Source: Psych Central - December 23, 2018 Category: Psychiatry Authors: Claire Nana Tags: Book Reviews Disorders General Neuroscience Personality Psychological Assessment Psychology Psychotherapy Trauma Treatment epigenetics Neurobiology Neurobiology For Clinical Social Work Physiology Source Type: news

Yale-led team examines impact of diet intervention on autoimmunity in mice
A new Yale-led study suggests that a change in diet — specifically adding more fiber — could be beneficial to people with autoimmune diseases such as lupus. (Source: Yale Science and Health News)
Source: Yale Science and Health News - December 20, 2018 Category: Universities & Medical Training Source Type: news

Here ’s the Best Way to Boost Your Immune System
Some people seem to breeze through cold-and-flu season without so much as a sniffle. What’s their secret? Regular exercise is a prime candidate. “If you look at all the lifestyle factors that decrease the number of days you suffer from common cold, being a physically active and fit person is the most important,” says David Nieman, a professor of public health and director of the Human Performance Lab at Appalachian State University. Nieman has spent years examining the effect exercise has on human health and immune function. In one of his studies, he and his colleagues found that 30 minutes of brisk walki...
Source: TIME: Health - December 20, 2018 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Research Source Type: news

Here's the Best Way to Boost Your Immune System
Some people seem to breeze through cold-and-flu season without so much as a sniffle. What’s their secret? Regular exercise is a prime candidate. “If you look at all the lifestyle factors that decrease the number of days you suffer from common cold, being a physically active and fit person is the most important,” says David Nieman, a professor of public health and director of the Human Performance Lab at Appalachian State University. Nieman has spent years examining the effect exercise has on human health and immune function. In one of his studies, he and his colleagues found that 30 minutes of brisk walki...
Source: TIME: Health - December 20, 2018 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Research Source Type: news

Yale-led team examines impact of diet intervention on autoimmunity in mice
(Yale University) Could a change in diet be beneficial to people with autoimmune diseases such as lupus? A Yale-led team of researchers have revealed how a dietary intervention can help prevent the development of this autoimmune disease in susceptible mice. The study was published in Cell Host& Microbe. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 20, 2018 Category: International Medicine & Public Health Source Type: news

RNA proofreading mistakes drive group of autoimmune diseases
(Scripps Research Institute) Study shows how mistakes in an RNA proofreading system can generate out-of-control interferon signaling, setting off development of autoimmune disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 19, 2018 Category: International Medicine & Public Health Source Type: news

How to eliminate the threat of autoimmune disorders safely and naturally
(Natural News) At least 50 million Americans have some form of autoimmune disease, and some individuals may even live with more than one. Unfortunately, food produced in the country is becoming more processed and contains more GMOs (genetically modified organisms) than ever, which can only worsen the conditions of people with autoimmune disorders. What is the... (Source: NaturalNews.com)
Source: NaturalNews.com - December 19, 2018 Category: Consumer Health News Source Type: news

Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders
Atopic dermatitis has been associated with numerous non-allergic comorbidities in both children and adults, including infections, neuropsychiatric conditions, obesity, and autoimmune disease.American Journal of Clinical Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 18, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Gut microbiome regulates the intestinal immune system, researchers find
(Brown University) A new study in mice unveils the role of vitamin A in immune system regulation, a finding that could assist in developing treatments for autoimmune and inflammatory diseases as well as vitamin A deficiency. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 18, 2018 Category: International Medicine & Public Health Source Type: news

Protein police keep the immune system in check
(Okinawa Institute of Science and Technology (OIST) Graduate University) Researchers learn how a key transcription factor helps regulate the immune system and could be critical to understanding autoimmune disease and cancer immunosuppression. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 17, 2018 Category: International Medicine & Public Health Source Type: news

Before He Died, Paul Allen Gifted $125 Million To A New Institute To Study The Immune System
The new institute will study the immune systems of healthy people, those with cancer, and those with autoimmune diseases. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 12, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Source Type: news

Harrington Discovery Institute at University Hospitals announces 2019 grant funding
(University Hospitals Cleveland Medical Center) The Harrington Discovery Institute at University Hospitals has announced the 2019 Harrington Scholar-Innovator Award recipients. Projects supported by the awards include new therapeutics to treat metabolic disorders, autoimmune disorders and cancer, and new approaches to eradicate parasitic diseases in developing countries. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

Purdue developing new treatment options for millions with autoimmune diseases
(Purdue University) Purdue University researchers have developed a series of molecules that may provide more reliable relief with fewer side effects for people with any of several autoimmune diseases. The new molecules overcome difficulties with current drugs in targeting, for purposes of inhibiting, the appropriate form of Janus kinase, which has four forms affecting cell signaling and gene expression. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 6, 2018 Category: International Medicine & Public Health Source Type: news